Small ubiquitin-like modifier 1-3 is activated in human astrocytic brain tumors and is required for glioblastoma cell survival
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small ubiquitin-like modifier 1-3 is activated in human astrocytic brain tumors and is required for glioblastoma cell survival
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 104, Issue 1, Pages 70-77
Publisher
Wiley
Online
2012-10-19
DOI
10.1111/cas.12047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair
- (2012) Y. Galanty et al. GENES & DEVELOPMENT
- DNA Damage Response and Growth Factor Signaling Pathways in Gliomagenesis and Therapeutic Resistance
- (2011) M. Squatrito et al. CANCER RESEARCH
- Purification and identification of endogenous polySUMO conjugates
- (2011) Roland Bruderer et al. EMBO REPORTS
- Analysis of Oxygen/Glucose-Deprivation-Induced Changes in SUMO3 Conjugation Using SILAC-Based Quantitative Proteomics
- (2011) Wei Yang et al. JOURNAL OF PROTEOME RESEARCH
- Serine phosphorylation of glutathione S-transferase P1 (GSTP1) by PKCα enhances GSTP1-dependent cisplatin metabolism and resistance in human glioma cells
- (2010) Simendra Singh et al. BIOCHEMICAL PHARMACOLOGY
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues
- (2010) Stergios J. Moschos et al. HUMAN PATHOLOGY
- SENP1 Induces Prostatic Intraepithelial Neoplasia through Multiple Mechanisms
- (2010) Tasneem Bawa-Khalfe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative Stress
- (2010) Yan Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of SUMO:SIM-mediated protein–protein interaction in non-homologous end joining
- (2010) Y-J Li et al. ONCOGENE
- Participation of DNA-PKcs in DSB Repair after Exposure to High- and Low-LET Radiation
- (2010) Jennifer A. Anderson et al. RADIATION RESEARCH
- Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression
- (2009) Wei Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation
- (2009) Chao Huang et al. EMBO JOURNAL
- Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks
- (2009) Yaron Galanty et al. NATURE
- Principles of ubiquitin and SUMO modifications in DNA repair
- (2009) Steven Bergink et al. NATURE
- VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
- (2009) Elizabeth R. Gerstner et al. Nature Reviews Clinical Oncology
- Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner
- (2009) S Zhu et al. ONCOGENE
- SUMO Modification Regulates BLM and RAD51 Interaction at Damaged Replication Forks
- (2009) Karen J. Ouyang et al. PLOS BIOLOGY
- Loss of Protein Inhibitors of Activated STAT-3 Expression in Glioblastoma Multiforme Tumors: Implications for STAT-3 Activation and Gene Expression
- (2008) E. C. Brantley et al. CLINICAL CANCER RESEARCH
- Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
- (2008) A. M. Spence et al. CLINICAL CANCER RESEARCH
- A PP4-Phosphatase Complex Dephosphorylates γ-H2AX Generated during DNA Replication
- (2008) Dipanjan Chowdhury et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started